DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced financial results for its fourth quarter of fiscal 2007 ended March 31, 2007. Revenue for the fourth quarter of fiscal 2007 was $13.9 million and revenue for the full fiscal year 2007 reached $50.6 million, up approximately 16% over fiscal year 2006. For the full fiscal year 2007, revenue from its AB5000 product platform was up 38%, BVS declined 22%, and Impella was up 87%.
